Ketamine Medical Treatment: Uses, Risks & Safety Guide

When people search for ketamine medical treatment, they are often trying to understand why ketamine has become a topic of interest in modern healthcare. Ketamine has been used medically for many years, particularly as an anesthetic, but researchers and clinicians have also studied its effects in several other areas of medicine. In recent years, interest in ketamine medical treatment has grown especially around depression that has not responded adequately to conventional treatments.

At the same time, ketamine is not a simple or universally appropriate treatment. The word “ketamine” can refer to different medical products, formulations, and clinical uses. Ketamine itself is an FDA-approved injectable anesthetic, while esketamine, a related medicine derived from one component of ketamine, has a separate FDA-approved nasal-spray indication for certain adults with depression. FDA states that ketamine itself is not FDA-approved for treatment of psychiatric disorders.

That distinction is extremely important when researching ketamine medical treatment. Online discussions sometimes describe ketamine as if it were an approved treatment for every mental health condition. That is not accurate. Evidence, regulatory approval, treatment setting, patient eligibility, and medical supervision all matter.

This Health2Organ guide explains ketamine medical treatment in clear and accessible language. It discusses what ketamine is, how it works in the body, its established medical role as an anesthetic, its investigated psychiatric uses, the difference between ketamine and esketamine, possible benefits, potential risks, safety considerations, treatment settings, and common questions people ask before considering this type of care.

What Is Ketamine Medical Treatment?

The term ketamine medical treatment can describe the use of ketamine under medical supervision for an established clinical purpose. Ketamine is a dissociative anesthetic that has been used in medicine for decades. In the United States, FDA-approved ketamine products are injectable medicines indicated for general anesthesia, including induction and maintenance of anesthesia for diagnostic and surgical procedures.

The phrase ketamine medical treatment is sometimes used more broadly online to describe ketamine being administered for psychiatric conditions or chronic pain. However, these uses may be outside the specific indications approved by a country’s medicine regulator. This is commonly referred to as off-label use when permitted by local regulations.

For example, FDA states that ketamine itself is not approved for the treatment of psychiatric disorders. FDA-approved esketamine, which is chemically related to ketamine, is a different medicine with specific approved uses for adults with treatment-resistant depression and certain depressive symptoms associated with major depressive disorder with acute suicidal ideation or behavior, in conjunction with an oral antidepressant.

Therefore, anyone researching ketamine medical treatment should first identify which medicine is actually being discussed and what medical condition it is being used to treat.

Why Has Ketamine Medical Treatment Received So Much Attention?

Interest in ketamine medical treatment has increased because researchers have observed that ketamine can affect certain brain signaling systems differently from many traditional antidepressants.

Traditional antidepressant medicines often act on neurotransmitter systems such as serotonin, norepinephrine, or dopamine. Ketamine primarily affects the glutamate system through NMDA receptor activity. This difference has encouraged researchers to investigate whether ketamine-related medicines may have therapeutic effects that occur through pathways different from conventional antidepressants.

Research has been particularly focused on treatment-resistant depression, a form of depression in which a person has not achieved sufficient improvement from previous treatments.

A 2023 evidence review found that ketamine may provide short-term improvements in depressive symptoms for some adults with treatment-resistant depression, but the certainty of evidence varies and important questions remain regarding longer-term effects and appropriate treatment strategies.

This means the growing interest in ketamine medical treatment should be understood alongside the limitations of current evidence rather than as proof that ketamine is a universal solution for depression.

How Does Ketamine Medical Treatment Work?

Understanding ketamine medical treatment requires understanding how ketamine affects the brain.

Ketamine primarily acts as an antagonist at NMDA receptors, which are involved in the brain’s glutamate signaling system. Glutamate is one of the major excitatory neurotransmitters in the central nervous system.

The effects of ketamine are different from those of many traditional antidepressant medicines. Researchers believe that changes in glutamate-related signaling and downstream pathways may contribute to ketamine’s rapid effects on depressive symptoms in some patients.

However, the exact biological explanation for the antidepressant effects of ketamine is complex and continues to be studied. It would be misleading to say that one simple mechanism completely explains all clinical effects.

This is one reason ketamine medical treatment remains an active area of research. Scientists continue to investigate why some patients respond while others do not, how long benefits last, which treatment schedules are appropriate, and how ketamine should be combined with other forms of care.

What Is Ketamine Normally Used For?

One of the most established roles of ketamine is anesthesia.

FDA-approved ketamine products such as KETALAR are injectable medicines used as general anesthetics. They may be used for induction of anesthesia and for diagnostic or surgical procedures.

This traditional medical role is different from the psychiatric applications that are frequently discussed online.

When someone searches for ketamine medical treatment, it is therefore important to understand that ketamine is not a medicine that was originally developed specifically as an antidepressant. Its established anesthetic role is much broader and has a long history in clinical medicine.

The dose, route of administration, monitoring, and purpose of ketamine treatment depend on the medical indication. A ketamine treatment used during surgery should not be confused with an outpatient psychiatric protocol.

Ketamine Medical Treatment for Depression

One of the most discussed areas of ketamine medical treatment is depression, particularly treatment-resistant depression.

Treatment-resistant depression generally refers to depression that has not improved sufficiently after appropriate trials of conventional treatments. The exact definition can vary among studies and clinical settings.

Research has suggested that ketamine can produce relatively rapid changes in depressive symptoms in some adults with treatment-resistant depression. However, research findings are not identical across all studies, and questions remain about durability, repeated treatment, long-term safety, and which patients are most likely to benefit.

FDA has approved esketamine nasal spray for adults with treatment-resistant depression when used with an oral antidepressant. This is not the same as FDA approving ketamine itself as a psychiatric medicine.

Therefore, when discussing ketamine medical treatment for depression, the distinction between ketamine and esketamine is essential.

What Is Treatment-Resistant Depression?

Treatment-resistant depression is a term used when depressive symptoms remain significant despite previous treatment attempts.

People with treatment-resistant depression may have tried one or more antidepressants, psychotherapy, or other evidence-based interventions without achieving adequate improvement. The diagnosis and treatment approach should be determined by a qualified mental health professional.

Not everyone with depression needs or qualifies for ketamine medical treatment.

Ketamine-related treatment is generally considered within a broader treatment plan rather than as a replacement for every other form of depression care. Depending on the individual, treatment may include psychotherapy, conventional antidepressants, lifestyle support, or other medical interventions.

A professional assessment is important because depression can have many different presentations and causes.

Ketamine Medical Treatment and Esketamine Are Not the Same

A major source of confusion in online searches about ketamine medical treatment is the assumption that ketamine and esketamine are simply different brand names for exactly the same treatment.

Ketamine is a racemic mixture containing two mirror-image molecules called R-ketamine and S-ketamine. Esketamine is the S-enantiomer of ketamine. FDA-approved esketamine is marketed as SPRAVATO and is administered as a nasal spray under specific conditions.

FDA states that esketamine is approved for treatment-resistant depression in adults and for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, in conjunction with an oral antidepressant.

Ketamine itself, by contrast, remains FDA-approved as an anesthetic and is not FDA-approved for psychiatric disorders.

This distinction should always be included in responsible content about ketamine medical treatment.

What Is Esketamine Treatment?

Esketamine is a prescription medicine delivered as a nasal spray. It is a derivative of ketamine and belongs to the NMDA receptor antagonist class.

In the United States, FDA requires esketamine to be administered through a restricted safety program known as the Spravato REMS. Patients are monitored after administration because the medicine can cause sedation, dissociation, changes in blood pressure, impaired judgment, and other effects.

This supervised approach is an important safety feature of approved esketamine treatment.

Therefore, people searching for ketamine medical treatment should not assume that an online ketamine product or a home-use product is equivalent to an FDA-approved esketamine treatment program.

How Is Ketamine Medical Treatment Administered?

The route of administration depends on the specific medical use and product.

FDA-approved ketamine for anesthesia is an injectable medicine and is administered by healthcare professionals in appropriate medical settings.

Esketamine for approved psychiatric indications is delivered as a nasal spray in a certified healthcare setting under the FDA’s restricted program. Patients are monitored after receiving the medicine.

Other forms of ketamine, including compounded oral or nasal products, may be discussed in online ketamine medical treatment advertisements. However, FDA has specifically warned about risks associated with compounded ketamine products marketed for psychiatric conditions.

The route of administration therefore matters greatly. A product’s formulation, purity, dose, storage, and supervision can all affect safety.

What Happens During a Supervised Ketamine Treatment?

The experience of ketamine medical treatment depends on why the medicine is being administered and which formulation is used.

When ketamine is used as an anesthetic, the patient is treated in a medical environment where clinicians monitor vital functions and provide appropriate anesthesia care.

When esketamine is used for an approved psychiatric indication, it is administered in a healthcare setting and the patient is monitored afterward. FDA’s prescribing information specifies monitoring for at least two hours following administration.

Patients may experience temporary changes in perception, sedation, dizziness, dissociation, nausea, or other effects.

Because these effects can temporarily impair attention, judgment, and coordination, supervised treatment is an important part of the safety process.

What Does Dissociation Mean During Ketamine Treatment?

Dissociation is one of the effects people may encounter when researching ketamine medical treatment.

Dissociation can involve a temporary feeling of being detached from one’s surroundings, body, thoughts, or sense of time. Some people describe unusual sensory experiences or a feeling that their environment is unreal.

FDA lists dissociation among the risks associated with esketamine treatment and states that patients may experience temporary impairment in attention, judgment, thinking, and motor skills.

This does not mean every patient experiences severe dissociation. Individual responses vary.

However, the possibility of altered perception is one reason ketamine-related psychiatric treatment should be conducted in an appropriate medical environment rather than treated like an ordinary home medication.

What Are the Potential Benefits of Ketamine Medical Treatment?

The potential benefits of ketamine medical treatment depend strongly on the medical condition and treatment approach.

For treatment-resistant depression, research suggests that ketamine can produce relatively rapid improvement in depressive symptoms in some patients. A 2023 evidence review found possible short-term benefits, although it also emphasized uncertainty surrounding some outcomes.

Esketamine has undergone controlled clinical studies supporting its approved use for certain adults with treatment-resistant depression. FDA reviewed evidence from clinical trials when evaluating its approval.

However, the potential for rapid symptom improvement should not be interpreted as a guarantee.

People respond differently to psychiatric treatments. Some may experience meaningful improvement, while others may experience limited benefit or adverse effects.

Does Ketamine Medical Treatment Work Quickly?

One reason ketamine medical treatment has attracted attention is the possibility of relatively rapid effects on depressive symptoms.

Traditional antidepressants can take time before their full effects are apparent. Research into ketamine has found changes in depressive symptoms in some patients within a relatively short period.

However, “rapid” does not mean immediate or guaranteed, and it does not mean the treatment permanently resolves depression after one administration.

The duration of benefit can vary, and repeated treatment protocols require careful clinical assessment.

The evidence review published through NCBI found that some studies suggested improvement within 24 hours or several days in treatment-resistant depression, but also emphasized uncertainty and variation in the evidence.

Therefore, ketamine medical treatment should be viewed as a potential therapeutic option in appropriate circumstances, not as an instant cure.

How Long Do the Effects of Ketamine Medical Treatment Last?

The duration of effects is another important question.

Some patients in research studies have experienced benefits that continue beyond the immediate treatment period, while others may experience shorter-lasting effects.

The duration can depend on the condition being treated, the treatment protocol, individual biology, previous treatments, and other factors.

Research on repeated ketamine treatment continues to examine whether benefits can be maintained safely over longer periods. Evidence reviews have noted uncertainty around the long-term effectiveness and safety of repeated treatment.

This means ketamine medical treatment should not be described as a permanent solution for depression.

A healthcare professional should monitor symptoms over time and determine whether continued treatment is appropriate.

What Are the Common Side Effects?

People researching ketamine medical treatment should understand the possible adverse effects before considering treatment.

Ketamine and esketamine can cause effects such as dizziness, nausea, sedation, dissociation, changes in blood pressure, altered perception, and impaired coordination.

FDA’s esketamine prescribing information lists dissociation, dizziness, nausea, sedation, vertigo, increased blood pressure, vomiting, headache, anxiety, and other effects among reported adverse reactions.

The severity and duration of these effects can differ among individuals.

This is one reason clinical monitoring matters. A healthcare professional can observe the patient’s response and determine whether additional medical attention is required.

What Are the Serious Safety Concerns?

Although ketamine medical treatment can have legitimate medical applications, ketamine-related medicines are not risk-free.

FDA’s boxed warning for esketamine addresses sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors in certain populations taking antidepressants.

FDA also warns that esketamine can temporarily impair attention, judgment, thinking, reaction speed, and motor skills.

Ketamine is a controlled substance and has potential for misuse and abuse.

These risks are especially relevant when people encounter online advertisements offering ketamine products without appropriate medical evaluation or supervision.

Why Medical Supervision Matters

Medical supervision is a central part of safe ketamine medical treatment.

A healthcare professional can evaluate whether the treatment is appropriate, review medications and health conditions, monitor vital signs, recognize adverse reactions, and provide appropriate support.

For FDA-approved esketamine, the restricted REMS program requires administration in certified healthcare settings and monitoring after treatment.

This is different from purchasing a ketamine product online and taking it without clinical oversight.

FDA has issued multiple warnings about unapproved and compounded ketamine products marketed for psychiatric uses, emphasizing the potential risks of products that have not undergone the same regulatory review as approved medicines.

Ketamine Medical Treatment and Blood Pressure

Blood pressure is another consideration in ketamine medical treatment.

Ketamine and esketamine can cause temporary increases in blood pressure. FDA specifically identifies increased blood pressure as a warning and precaution for esketamine.

People with certain cardiovascular or cerebrovascular conditions may require particular evaluation before receiving treatment.

This does not mean that everyone with a history of blood pressure problems is automatically unable to receive every ketamine-related treatment. Rather, medical eligibility should be assessed individually.

A healthcare professional can determine whether the potential benefits and risks are appropriate for a particular patient.

Ketamine Medical Treatment and Mental Health Conditions

Ketamine has been studied in several psychiatric conditions, including treatment-resistant depression and post-traumatic stress disorder.

However, evidence does not have the same strength for every condition.

A 2023 evidence review examining ketamine for treatment-resistant depression and PTSD found evidence suggesting possible benefits in some treatment-resistant depression outcomes but considerably more uncertainty around PTSD outcomes.

This is important because online content sometimes presents ketamine as an established treatment for numerous psychiatric disorders.

Responsible information about ketamine medical treatment should distinguish between established regulatory indications, off-label clinical practice, and experimental or research uses.

Ketamine Medical Treatment for PTSD

Ketamine has been investigated as a potential treatment for PTSD, but the evidence is not as established as some online advertising may suggest.

The 2023 evidence review found uncertainty about ketamine’s effects on PTSD symptoms compared with placebo.

Research continues to investigate whether ketamine combined with psychotherapy may have benefits for certain people with PTSD. A 2026 systematic review examined ketamine-assisted psychotherapy and predictors of treatment response, reflecting ongoing research in this area.

This means ketamine medical treatment for PTSD should not be presented as a universally proven or approved therapy.

People with PTSD should receive an individualized assessment from a qualified mental health professional.

Ketamine Medical Treatment and Pain

Ketamine also has a history in medicine beyond anesthesia and psychiatric research.

Its effects on the nervous system have led clinicians and researchers to investigate ketamine for certain pain-related conditions. However, the evidence and regulatory status vary according to the type of pain, formulation, dose, treatment setting, and country.

This is another reason that ketamine medical treatment should not be treated as one standardized therapy.

A person with chronic pain should receive a proper medical assessment to identify the underlying condition and consider evidence-based treatment options.

Ketamine should not be self-administered for pain based on information found on an internet marketplace.

Is Ketamine Medical Treatment FDA Approved for Depression?

This question deserves a very clear answer.

Ketamine itself is not FDA-approved for treatment of psychiatric disorders. FDA-approved ketamine products are indicated as anesthetics.

Esketamine, marketed as SPRAVATO, is FDA-approved for specific depression-related indications. It is used with an oral antidepressant and administered through a restricted healthcare program.

Therefore, an article about ketamine medical treatment should never state simply that “ketamine is FDA-approved for depression.” That statement would blur the distinction between ketamine and esketamine.

The regulatory status of medicines can also differ between countries, so readers outside the United States should consult their national medicine regulator or healthcare professional for local information.

Is At-Home Ketamine Treatment Safe?

At-home ketamine treatment is a complicated topic because different products and jurisdictions may involve different regulations.

FDA has warned about compounded ketamine products promoted for psychiatric disorders, including concerns about dosing, monitoring, adverse effects, and the absence of FDA approval for these psychiatric uses.

A person should therefore be cautious about online services that promise quick mental health treatment with ketamine without an adequate medical evaluation.

The fact that a product is described as “medical” or “prescription” online does not automatically mean that it is an FDA-approved treatment for the advertised condition.

For safe ketamine medical treatment, patients should know what medicine they are receiving, why it is being used, who is prescribing it, how it will be monitored, and what medical support is available if an adverse reaction occurs.

Why Buying Ketamine Online Can Be Risky

Online availability can make medicines appear easier to obtain than they should be.

FDA has recently issued warning letters concerning websites selling unapproved and misbranded ketamine products. The agency has noted that unapproved products may not provide the same assurances of safety, quality, effectiveness, identity, or manufacturing standards as approved medicines.

Some products may contain incorrect amounts of active ingredients, different ingredients, or contaminants.

For this reason, people interested in ketamine medical treatment should avoid treating online product listings as substitutes for legitimate medical care.

A qualified healthcare professional should determine whether treatment is appropriate and what formulation is suitable.

What Should a Patient Ask Before Ketamine Medical Treatment?

Before beginning ketamine medical treatment, patients can ask several practical questions.

They can ask which medicine is being recommended and whether it is ketamine or esketamine. They can ask what condition the medicine is being used to treat and whether that use is approved or off-label in their country.

They can also ask where treatment will occur, how long monitoring will continue, what side effects may occur, what medications or health conditions could affect eligibility, and what follow-up care will be provided.

These questions can help patients understand what they are actually receiving rather than relying on a general label such as “ketamine therapy.”

Who Should Not Use Ketamine Without Medical Advice?

Ketamine should not be used casually or recreationally as a substitute for medical treatment.

Certain medical conditions can increase risks associated with ketamine or esketamine. FDA’s prescribing information for esketamine lists specific contraindications, including certain aneurysmal vascular diseases, arteriovenous malformations, intracerebral hemorrhage, and hypersensitivity to esketamine, ketamine, or certain ingredients.

The appropriateness of ketamine medical treatment can also be affected by other medicines, cardiovascular conditions, pregnancy considerations, substance-use history, and psychiatric circumstances.

A healthcare professional should review the patient’s medical history before treatment.

Ketamine Medical Treatment During Pregnancy

Pregnancy is an important consideration when discussing ketamine medical treatment.

FDA’s esketamine prescribing information warns of potential embryo-fetal toxicity and recommends consideration of pregnancy planning and prevention for females of reproductive potential.

This does not mean that every exposure has the same outcome or that pregnancy automatically answers every clinical question. It means pregnancy status and reproductive plans should be discussed with the treating healthcare professional.

Anyone who is pregnant, planning pregnancy, or breastfeeding should tell the healthcare professional before receiving ketamine or esketamine.

Can Ketamine Be Combined With Other Treatments?

Ketamine-related treatments may be used alongside other forms of care depending on the clinical situation.

For example, FDA-approved esketamine for treatment-resistant depression is used in conjunction with an oral antidepressant.

Psychotherapy may also remain an important component of treatment for depression, PTSD, anxiety disorders, and other mental health conditions.

The decision to combine ketamine medical treatment with other therapies should be made by qualified professionals who understand the patient’s diagnosis, medications, risks, and treatment history.

People should not independently combine ketamine with other sedating or psychoactive substances.

Ketamine Medical Treatment and Substance Misuse

Ketamine has legitimate medical applications, but it is also a controlled substance with potential for misuse and abuse.

FDA specifically identifies abuse and misuse as important risks associated with esketamine and ketamine-related medicines.

This is particularly relevant for people who have a current or previous substance-use disorder.

Medical professionals can consider these risks when deciding whether treatment is appropriate and how treatment should be monitored.

Using ketamine without medical supervision is substantially different from receiving ketamine medical treatment within a structured clinical program.

What Does the Future Look Like for Ketamine Medical Treatment?

Research into ketamine medical treatment continues to develop.

Researchers are studying which patients respond best, how treatment effects can be maintained, how ketamine can be integrated with psychotherapy, and whether new ketamine-related medicines can provide therapeutic effects with fewer risks.

Research into ketamine-assisted psychotherapy for PTSD is one example of this developing field.

However, scientific interest does not automatically mean that a treatment has established approval for every condition.

Future evidence may change clinical recommendations, but current treatment decisions should be based on the best available evidence and applicable medical guidance.

How Should Patients Evaluate Ketamine Treatment Claims Online?

People searching for ketamine medical treatment may encounter websites promising dramatic results.

A useful way to evaluate such claims is to look for clear information about the medicine, indication, evidence, risks, regulatory status, clinician qualifications, monitoring process, and follow-up care.

Claims such as “works for everyone,” “completely safe,” or “permanent cure” should be treated cautiously because medical treatments rarely have universal outcomes.

FDA has specifically warned about online sellers offering unapproved ketamine products and highlighted risks associated with products that lack appropriate regulatory safeguards.

Reliable health information should present both potential benefits and limitations.

Ketamine Medical Treatment and Informed Decision-Making

Informed decision-making means understanding what a treatment can realistically offer and what its limitations are.

For ketamine medical treatment, this includes knowing whether the medicine is ketamine or esketamine, whether the intended use is approved or off-label, what evidence supports the treatment, what risks exist, and what monitoring will be provided.

It also means understanding that individual response cannot be guaranteed.

Patients should have an opportunity to discuss questions with their healthcare professional and should not feel pressured to purchase a treatment simply because a website describes it as innovative or fast-acting.

FAQs

What is ketamine medical treatment?

Ketamine medical treatment refers broadly to the clinical use of ketamine under professional supervision. Ketamine is an established injectable anesthetic, while some ketamine-related uses in psychiatry are off-label. FDA-approved esketamine has specific indications for certain adults with depression.

Is ketamine approved for depression?

Ketamine itself is not FDA-approved for psychiatric disorders. FDA has approved esketamine nasal spray for specific depression-related indications, including treatment-resistant depression in adults, with an oral antidepressant and under a restricted monitoring program.

What are the side effects of ketamine medical treatment?

Possible effects include sedation, dizziness, nausea, dissociation, changes in blood pressure, altered perception, and temporary impairment of attention or coordination. Esketamine’s FDA prescribing information also includes warnings concerning respiratory depression, abuse and misuse, and other serious risks.

Can ketamine medical treatment be done at home?

Some online services advertise home-use ketamine products, but FDA has warned about risks associated with compounded and unapproved ketamine products used for psychiatric purposes. Appropriate treatment should involve a qualified healthcare professional who can determine whether the medicine and treatment setting are suitable.

Can ketamine treat treatment-resistant depression?

Research suggests that ketamine can reduce depressive symptoms relatively rapidly in some adults with treatment-resistant depression, but the evidence varies and questions remain about long-term effectiveness and safety. Esketamine has an FDA-approved indication for treatment-resistant depression in adults under specific conditions.

Final Thoughts on Ketamine Medical Treatment

Ketamine medical treatment is an evolving area of modern healthcare that combines a long-established anesthetic medicine with newer research into depression and other conditions.

Ketamine has a well-established medical role as an anesthetic. Its effects on the brain have also led researchers to investigate its potential role in treatment-resistant depression and other psychiatric conditions. Evidence suggests that some patients with treatment-resistant depression may experience relatively rapid improvement in symptoms after ketamine treatment, although the strength and durability of the evidence vary.

It is particularly important to distinguish ketamine from esketamine. FDA states that ketamine itself is not approved for psychiatric disorders, while esketamine is an FDA-approved nasal spray for specific depression-related indications under a restricted monitoring program.

Safety is another central part of ketamine medical treatment. Ketamine and esketamine can cause sedation, dissociation, changes in blood pressure, impaired judgment, nausea, and other adverse effects. Esketamine also carries a boxed warning concerning sedation, dissociation, respiratory depression, abuse and misuse, and other risks.

For these reasons, ketamine medical treatment should never be approached as an ordinary wellness product or as something that can automatically be used safely without professional oversight. FDA has warned about unapproved and compounded ketamine products marketed online, emphasizing that such products may not provide the same regulatory assurances as approved medicines.

Anyone considering ketamine medical treatment should discuss the option with a qualified healthcare professional who can review the diagnosis, medical history, current medicines, potential risks, treatment goals, and appropriate alternatives.

The most useful way to think about ketamine medical treatment is not as a universal cure, but as a medical intervention with specific established uses, developing evidence in some areas, meaningful potential risks, and a need for appropriate clinical supervision. Accurate information and professional medical assessment are essential when deciding whether any ketamine-related treatment is appropriate for an individual.